Clinical Trial Update: Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a cardiovascular preventive strategy in chronic myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: University Hospital, Angers | Conditions: Chronic Myeloid Leukemia (CML) | Phase 3 | Status: TERMINATED